The global Medical Hyaluronic Acid Injection market size was valued at US$ 10110 million in 2024 and is forecast to a readjusted size of USD 19870 million by 2031 with a CAGR of 10.3% during review period.
Hyaluronic acid is a type of sugar (polysaccharide) that is present in body tissues, such as in skin and cartilage. It is able to combine with water and swell when in gel form, causing a smoothing/filling effect.
The medical cross-linked hyaluronic acid gel market is driven by the rising demand for minimally invasive cosmetic procedures and the desire for youthful and rejuvenated skin. Cross-linked hyaluronic acid gels are commonly used as dermal fillers to enhance facial features, reduce wrinkles, and restore volume. The increase in aesthetic consciousness and the preference for non-surgical treatments contribute to market growth as individuals seek natural-looking and temporary enhancements without undergoing extensive surgery. Moreover, advancements in filler technology and formulations have improved safety and longevity, further boosting market demand. However, the market also faces challenges, including the need for skilled and trained practitioners for optimal results and addressing potential side effects or adverse reactions. Additionally, navigating regulatory guidelines and ensuring patient safety while delivering personalized aesthetic solutions can pose challenges for manufacturers and providers. To thrive, companies must focus on research and development to offer innovative and safe cross-linked hyaluronic acid gels, collaborate with qualified professionals to ensure proper application, and address the challenges to meet the increasing demand for effective and personalized non-surgical cosmetic enhancements.
This report is a detailed and comprehensive analysis for global Medical Hyaluronic Acid Injection market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Medical Hyaluronic Acid Injection market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global Medical Hyaluronic Acid Injection market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global Medical Hyaluronic Acid Injection market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global Medical Hyaluronic Acid Injection market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Medical Hyaluronic Acid Injection
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Medical Hyaluronic Acid Injection market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include AbbVie, Galderma, LG Life Sciences, Merz, Medytox, HUGEL, Croma-Pharma, Beijing IMEIK, Bloomage Bio, Sanofi, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
麻豆原创 Segmentation
Medical Hyaluronic Acid Injection market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
麻豆原创 segment by Type
Aesthetic Filler
Bone Grade
Eye Grade
麻豆原创 segment by Application
Hospital
Clinic
Other
Major players covered
AbbVie
Galderma
LG Life Sciences
Merz
Medytox
HUGEL
Croma-Pharma
Beijing IMEIK
Bloomage Bio
Sanofi
Anika Therapeutics
Seikagaku
Zimmer Biomet
Bioventus
Ferring
LG Chem
Freda
麻豆原创 segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Medical Hyaluronic Acid Injection product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Medical Hyaluronic Acid Injection, with price, sales quantity, revenue, and global market share of Medical Hyaluronic Acid Injection from 2020 to 2025.
Chapter 3, the Medical Hyaluronic Acid Injection competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Medical Hyaluronic Acid Injection breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Medical Hyaluronic Acid Injection market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Medical Hyaluronic Acid Injection.
Chapter 14 and 15, to describe Medical Hyaluronic Acid Injection sales channel, distributors, customers, research findings and conclusion.
Please Note - This is an on demand report and will be delivered in 2 business days (48 Hours) post payment.
1 麻豆原创 Overview
1.1 Product Overview and Scope
1.2 麻豆原创 Estimation Caveats and Base Year
1.3 麻豆原创 Analysis by Type
1.3.1 Overview: Global Medical Hyaluronic Acid Injection Consumption Value by Type: 2020 Versus 2024 Versus 2031
1.3.2 Aesthetic Filler
1.3.3 Bone Grade
1.3.4 Eye Grade
1.4 麻豆原创 Analysis by Application
1.4.1 Overview: Global Medical Hyaluronic Acid Injection Consumption Value by Application: 2020 Versus 2024 Versus 2031
1.4.2 Hospital
1.4.3 Clinic
1.4.4 Other
1.5 Global Medical Hyaluronic Acid Injection 麻豆原创 Size & Forecast
1.5.1 Global Medical Hyaluronic Acid Injection Consumption Value (2020 & 2024 & 2031)
1.5.2 Global Medical Hyaluronic Acid Injection Sales Quantity (2020-2031)
1.5.3 Global Medical Hyaluronic Acid Injection Average Price (2020-2031)
2 Manufacturers Profiles
2.1 AbbVie
2.1.1 AbbVie Details
2.1.2 AbbVie Major Business
2.1.3 AbbVie Medical Hyaluronic Acid Injection Product and Services
2.1.4 AbbVie Medical Hyaluronic Acid Injection Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.1.5 AbbVie Recent Developments/Updates
2.2 Galderma
2.2.1 Galderma Details
2.2.2 Galderma Major Business
2.2.3 Galderma Medical Hyaluronic Acid Injection Product and Services
2.2.4 Galderma Medical Hyaluronic Acid Injection Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.2.5 Galderma Recent Developments/Updates
2.3 LG Life Sciences
2.3.1 LG Life Sciences Details
2.3.2 LG Life Sciences Major Business
2.3.3 LG Life Sciences Medical Hyaluronic Acid Injection Product and Services
2.3.4 LG Life Sciences Medical Hyaluronic Acid Injection Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.3.5 LG Life Sciences Recent Developments/Updates
2.4 Merz
2.4.1 Merz Details
2.4.2 Merz Major Business
2.4.3 Merz Medical Hyaluronic Acid Injection Product and Services
2.4.4 Merz Medical Hyaluronic Acid Injection Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.4.5 Merz Recent Developments/Updates
2.5 Medytox
2.5.1 Medytox Details
2.5.2 Medytox Major Business
2.5.3 Medytox Medical Hyaluronic Acid Injection Product and Services
2.5.4 Medytox Medical Hyaluronic Acid Injection Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.5.5 Medytox Recent Developments/Updates
2.6 HUGEL
2.6.1 HUGEL Details
2.6.2 HUGEL Major Business
2.6.3 HUGEL Medical Hyaluronic Acid Injection Product and Services
2.6.4 HUGEL Medical Hyaluronic Acid Injection Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.6.5 HUGEL Recent Developments/Updates
2.7 Croma-Pharma
2.7.1 Croma-Pharma Details
2.7.2 Croma-Pharma Major Business
2.7.3 Croma-Pharma Medical Hyaluronic Acid Injection Product and Services
2.7.4 Croma-Pharma Medical Hyaluronic Acid Injection Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.7.5 Croma-Pharma Recent Developments/Updates
2.8 Beijing IMEIK
2.8.1 Beijing IMEIK Details
2.8.2 Beijing IMEIK Major Business
2.8.3 Beijing IMEIK Medical Hyaluronic Acid Injection Product and Services
2.8.4 Beijing IMEIK Medical Hyaluronic Acid Injection Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.8.5 Beijing IMEIK Recent Developments/Updates
2.9 Bloomage Bio
2.9.1 Bloomage Bio Details
2.9.2 Bloomage Bio Major Business
2.9.3 Bloomage Bio Medical Hyaluronic Acid Injection Product and Services
2.9.4 Bloomage Bio Medical Hyaluronic Acid Injection Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.9.5 Bloomage Bio Recent Developments/Updates
2.10 Sanofi
2.10.1 Sanofi Details
2.10.2 Sanofi Major Business
2.10.3 Sanofi Medical Hyaluronic Acid Injection Product and Services
2.10.4 Sanofi Medical Hyaluronic Acid Injection Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.10.5 Sanofi Recent Developments/Updates
2.11 Anika Therapeutics
2.11.1 Anika Therapeutics Details
2.11.2 Anika Therapeutics Major Business
2.11.3 Anika Therapeutics Medical Hyaluronic Acid Injection Product and Services
2.11.4 Anika Therapeutics Medical Hyaluronic Acid Injection Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.11.5 Anika Therapeutics Recent Developments/Updates
2.12 Seikagaku
2.12.1 Seikagaku Details
2.12.2 Seikagaku Major Business
2.12.3 Seikagaku Medical Hyaluronic Acid Injection Product and Services
2.12.4 Seikagaku Medical Hyaluronic Acid Injection Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.12.5 Seikagaku Recent Developments/Updates
2.13 Zimmer Biomet
2.13.1 Zimmer Biomet Details
2.13.2 Zimmer Biomet Major Business
2.13.3 Zimmer Biomet Medical Hyaluronic Acid Injection Product and Services
2.13.4 Zimmer Biomet Medical Hyaluronic Acid Injection Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.13.5 Zimmer Biomet Recent Developments/Updates
2.14 Bioventus
2.14.1 Bioventus Details
2.14.2 Bioventus Major Business
2.14.3 Bioventus Medical Hyaluronic Acid Injection Product and Services
2.14.4 Bioventus Medical Hyaluronic Acid Injection Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.14.5 Bioventus Recent Developments/Updates
2.15 Ferring
2.15.1 Ferring Details
2.15.2 Ferring Major Business
2.15.3 Ferring Medical Hyaluronic Acid Injection Product and Services
2.15.4 Ferring Medical Hyaluronic Acid Injection Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.15.5 Ferring Recent Developments/Updates
2.16 LG Chem
2.16.1 LG Chem Details
2.16.2 LG Chem Major Business
2.16.3 LG Chem Medical Hyaluronic Acid Injection Product and Services
2.16.4 LG Chem Medical Hyaluronic Acid Injection Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.16.5 LG Chem Recent Developments/Updates
2.17 Freda
2.17.1 Freda Details
2.17.2 Freda Major Business
2.17.3 Freda Medical Hyaluronic Acid Injection Product and Services
2.17.4 Freda Medical Hyaluronic Acid Injection Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.17.5 Freda Recent Developments/Updates
3 Competitive Environment: Medical Hyaluronic Acid Injection by Manufacturer
3.1 Global Medical Hyaluronic Acid Injection Sales Quantity by Manufacturer (2020-2025)
3.2 Global Medical Hyaluronic Acid Injection Revenue by Manufacturer (2020-2025)
3.3 Global Medical Hyaluronic Acid Injection Average Price by Manufacturer (2020-2025)
3.4 麻豆原创 Share Analysis (2024)
3.4.1 Producer Shipments of Medical Hyaluronic Acid Injection by Manufacturer Revenue ($MM) and 麻豆原创 Share (%): 2024
3.4.2 Top 3 Medical Hyaluronic Acid Injection Manufacturer 麻豆原创 Share in 2024
3.4.3 Top 6 Medical Hyaluronic Acid Injection Manufacturer 麻豆原创 Share in 2024
3.5 Medical Hyaluronic Acid Injection 麻豆原创: Overall Company Footprint Analysis
3.5.1 Medical Hyaluronic Acid Injection 麻豆原创: Region Footprint
3.5.2 Medical Hyaluronic Acid Injection 麻豆原创: Company Product Type Footprint
3.5.3 Medical Hyaluronic Acid Injection 麻豆原创: Company Product Application Footprint
3.6 New 麻豆原创 Entrants and Barriers to 麻豆原创 Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Medical Hyaluronic Acid Injection 麻豆原创 Size by Region
4.1.1 Global Medical Hyaluronic Acid Injection Sales Quantity by Region (2020-2031)
4.1.2 Global Medical Hyaluronic Acid Injection Consumption Value by Region (2020-2031)
4.1.3 Global Medical Hyaluronic Acid Injection Average Price by Region (2020-2031)
4.2 North America Medical Hyaluronic Acid Injection Consumption Value (2020-2031)
4.3 Europe Medical Hyaluronic Acid Injection Consumption Value (2020-2031)
4.4 Asia-Pacific Medical Hyaluronic Acid Injection Consumption Value (2020-2031)
4.5 South America Medical Hyaluronic Acid Injection Consumption Value (2020-2031)
4.6 Middle East & Africa Medical Hyaluronic Acid Injection Consumption Value (2020-2031)
5 麻豆原创 Segment by Type
5.1 Global Medical Hyaluronic Acid Injection Sales Quantity by Type (2020-2031)
5.2 Global Medical Hyaluronic Acid Injection Consumption Value by Type (2020-2031)
5.3 Global Medical Hyaluronic Acid Injection Average Price by Type (2020-2031)
6 麻豆原创 Segment by Application
6.1 Global Medical Hyaluronic Acid Injection Sales Quantity by Application (2020-2031)
6.2 Global Medical Hyaluronic Acid Injection Consumption Value by Application (2020-2031)
6.3 Global Medical Hyaluronic Acid Injection Average Price by Application (2020-2031)
7 North America
7.1 North America Medical Hyaluronic Acid Injection Sales Quantity by Type (2020-2031)
7.2 North America Medical Hyaluronic Acid Injection Sales Quantity by Application (2020-2031)
7.3 North America Medical Hyaluronic Acid Injection 麻豆原创 Size by Country
7.3.1 North America Medical Hyaluronic Acid Injection Sales Quantity by Country (2020-2031)
7.3.2 North America Medical Hyaluronic Acid Injection Consumption Value by Country (2020-2031)
7.3.3 United States 麻豆原创 Size and Forecast (2020-2031)
7.3.4 Canada 麻豆原创 Size and Forecast (2020-2031)
7.3.5 Mexico 麻豆原创 Size and Forecast (2020-2031)
8 Europe
8.1 Europe Medical Hyaluronic Acid Injection Sales Quantity by Type (2020-2031)
8.2 Europe Medical Hyaluronic Acid Injection Sales Quantity by Application (2020-2031)
8.3 Europe Medical Hyaluronic Acid Injection 麻豆原创 Size by Country
8.3.1 Europe Medical Hyaluronic Acid Injection Sales Quantity by Country (2020-2031)
8.3.2 Europe Medical Hyaluronic Acid Injection Consumption Value by Country (2020-2031)
8.3.3 Germany 麻豆原创 Size and Forecast (2020-2031)
8.3.4 France 麻豆原创 Size and Forecast (2020-2031)
8.3.5 United Kingdom 麻豆原创 Size and Forecast (2020-2031)
8.3.6 Russia 麻豆原创 Size and Forecast (2020-2031)
8.3.7 Italy 麻豆原创 Size and Forecast (2020-2031)
9 Asia-Pacific
9.1 Asia-Pacific Medical Hyaluronic Acid Injection Sales Quantity by Type (2020-2031)
9.2 Asia-Pacific Medical Hyaluronic Acid Injection Sales Quantity by Application (2020-2031)
9.3 Asia-Pacific Medical Hyaluronic Acid Injection 麻豆原创 Size by Region
9.3.1 Asia-Pacific Medical Hyaluronic Acid Injection Sales Quantity by Region (2020-2031)
9.3.2 Asia-Pacific Medical Hyaluronic Acid Injection Consumption Value by Region (2020-2031)
9.3.3 China 麻豆原创 Size and Forecast (2020-2031)
9.3.4 Japan 麻豆原创 Size and Forecast (2020-2031)
9.3.5 South Korea 麻豆原创 Size and Forecast (2020-2031)
9.3.6 India 麻豆原创 Size and Forecast (2020-2031)
9.3.7 Southeast Asia 麻豆原创 Size and Forecast (2020-2031)
9.3.8 Australia 麻豆原创 Size and Forecast (2020-2031)
10 South America
10.1 South America Medical Hyaluronic Acid Injection Sales Quantity by Type (2020-2031)
10.2 South America Medical Hyaluronic Acid Injection Sales Quantity by Application (2020-2031)
10.3 South America Medical Hyaluronic Acid Injection 麻豆原创 Size by Country
10.3.1 South America Medical Hyaluronic Acid Injection Sales Quantity by Country (2020-2031)
10.3.2 South America Medical Hyaluronic Acid Injection Consumption Value by Country (2020-2031)
10.3.3 Brazil 麻豆原创 Size and Forecast (2020-2031)
10.3.4 Argentina 麻豆原创 Size and Forecast (2020-2031)
11 Middle East & Africa
11.1 Middle East & Africa Medical Hyaluronic Acid Injection Sales Quantity by Type (2020-2031)
11.2 Middle East & Africa Medical Hyaluronic Acid Injection Sales Quantity by Application (2020-2031)
11.3 Middle East & Africa Medical Hyaluronic Acid Injection 麻豆原创 Size by Country
11.3.1 Middle East & Africa Medical Hyaluronic Acid Injection Sales Quantity by Country (2020-2031)
11.3.2 Middle East & Africa Medical Hyaluronic Acid Injection Consumption Value by Country (2020-2031)
11.3.3 Turkey 麻豆原创 Size and Forecast (2020-2031)
11.3.4 Egypt 麻豆原创 Size and Forecast (2020-2031)
11.3.5 Saudi Arabia 麻豆原创 Size and Forecast (2020-2031)
11.3.6 South Africa 麻豆原创 Size and Forecast (2020-2031)
12 麻豆原创 Dynamics
12.1 Medical Hyaluronic Acid Injection 麻豆原创 Drivers
12.2 Medical Hyaluronic Acid Injection 麻豆原创 Restraints
12.3 Medical Hyaluronic Acid Injection Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 Raw Material and Industry Chain
13.1 Raw Material of Medical Hyaluronic Acid Injection and Key Manufacturers
13.2 Manufacturing Costs Percentage of Medical Hyaluronic Acid Injection
13.3 Medical Hyaluronic Acid Injection Production Process
13.4 Industry Value Chain Analysis
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Medical Hyaluronic Acid Injection Typical Distributors
14.3 Medical Hyaluronic Acid Injection Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
AbbVie
Galderma
LG Life Sciences
Merz
Medytox
HUGEL
Croma-Pharma
Beijing IMEIK
Bloomage Bio
Sanofi
Anika Therapeutics
Seikagaku
Zimmer Biomet
Bioventus
Ferring
LG Chem
Freda
听
听
*If Applicable.
